Renal disease in hypertensive adults

Effect of race and type II diabetes mellitus

W. M. Tierney, C. J. McDonald, F. C. Luft

Research output: Contribution to journalArticle

92 Citations (Scopus)

Abstract

To test the hypothesis that race is a predictor of hypertensive renal disease, we examined a general medicine clinic population of 6,880 hypertensive patients who were treated for at least 1 year (mean, 5.2 years). Their mean age was 55.8 years; 70% were women, 72% were black, and 41% were diabetic (95% type II). Many were already under treatment at the time of enrollment. Their mean blood pressure at entry was 150/92 mmHg; during treatment it was 142/86 mmHg. Decreased renal function, defined as a serum creatinine ≥ 2 mg/dL, developed in 18.1%. A multivariable logistic regression analysis identified diabetes, glucose control, systolic blood pressure levels, heart failure, and male gender as indicators of decreased renal function. These data suggested that glucose and blood pressure control may decrease the frequency of impaired renal function. However, when these variables were controlled, blacks still had almost twice the risk for renal dysfunction (91% greater risk) than whites (P < 0.0001). With increasing creatinine values, the percentage of black patients increased progressively. The data draw attention to and elucidate the exceptionally high incidence of renal dysfunction in blacks with or without diabetes. Further, they may explain the inordinate numbers of blacks with hypertension requiring dialysis. Finally, these retrospective data suggest that prospective trials to test the effect of blood pressure and glucose control on the course of renal disease in hypertensive and/or type II diabetic patients are warranted.

Original languageEnglish
Pages (from-to)485-493
Number of pages9
JournalAmerican Journal of Kidney Diseases
Volume13
Issue number6
StatePublished - 1989

Fingerprint

Type 2 Diabetes Mellitus
Kidney
Blood Pressure
Creatinine
Glucose
Blood Glucose
Dialysis
Heart Failure
Logistic Models
Regression Analysis
Medicine
Hypertension
Incidence
Therapeutics
Serum
Population

ASJC Scopus subject areas

  • Nephrology

Cite this

Renal disease in hypertensive adults : Effect of race and type II diabetes mellitus. / Tierney, W. M.; McDonald, C. J.; Luft, F. C.

In: American Journal of Kidney Diseases, Vol. 13, No. 6, 1989, p. 485-493.

Research output: Contribution to journalArticle

Tierney, W. M. ; McDonald, C. J. ; Luft, F. C. / Renal disease in hypertensive adults : Effect of race and type II diabetes mellitus. In: American Journal of Kidney Diseases. 1989 ; Vol. 13, No. 6. pp. 485-493.
@article{e234ff4553bb437daae826d274013426,
title = "Renal disease in hypertensive adults: Effect of race and type II diabetes mellitus",
abstract = "To test the hypothesis that race is a predictor of hypertensive renal disease, we examined a general medicine clinic population of 6,880 hypertensive patients who were treated for at least 1 year (mean, 5.2 years). Their mean age was 55.8 years; 70{\%} were women, 72{\%} were black, and 41{\%} were diabetic (95{\%} type II). Many were already under treatment at the time of enrollment. Their mean blood pressure at entry was 150/92 mmHg; during treatment it was 142/86 mmHg. Decreased renal function, defined as a serum creatinine ≥ 2 mg/dL, developed in 18.1{\%}. A multivariable logistic regression analysis identified diabetes, glucose control, systolic blood pressure levels, heart failure, and male gender as indicators of decreased renal function. These data suggested that glucose and blood pressure control may decrease the frequency of impaired renal function. However, when these variables were controlled, blacks still had almost twice the risk for renal dysfunction (91{\%} greater risk) than whites (P < 0.0001). With increasing creatinine values, the percentage of black patients increased progressively. The data draw attention to and elucidate the exceptionally high incidence of renal dysfunction in blacks with or without diabetes. Further, they may explain the inordinate numbers of blacks with hypertension requiring dialysis. Finally, these retrospective data suggest that prospective trials to test the effect of blood pressure and glucose control on the course of renal disease in hypertensive and/or type II diabetic patients are warranted.",
author = "Tierney, {W. M.} and McDonald, {C. J.} and Luft, {F. C.}",
year = "1989",
language = "English",
volume = "13",
pages = "485--493",
journal = "American Journal of Kidney Diseases",
issn = "0272-6386",
publisher = "W.B. Saunders Ltd",
number = "6",

}

TY - JOUR

T1 - Renal disease in hypertensive adults

T2 - Effect of race and type II diabetes mellitus

AU - Tierney, W. M.

AU - McDonald, C. J.

AU - Luft, F. C.

PY - 1989

Y1 - 1989

N2 - To test the hypothesis that race is a predictor of hypertensive renal disease, we examined a general medicine clinic population of 6,880 hypertensive patients who were treated for at least 1 year (mean, 5.2 years). Their mean age was 55.8 years; 70% were women, 72% were black, and 41% were diabetic (95% type II). Many were already under treatment at the time of enrollment. Their mean blood pressure at entry was 150/92 mmHg; during treatment it was 142/86 mmHg. Decreased renal function, defined as a serum creatinine ≥ 2 mg/dL, developed in 18.1%. A multivariable logistic regression analysis identified diabetes, glucose control, systolic blood pressure levels, heart failure, and male gender as indicators of decreased renal function. These data suggested that glucose and blood pressure control may decrease the frequency of impaired renal function. However, when these variables were controlled, blacks still had almost twice the risk for renal dysfunction (91% greater risk) than whites (P < 0.0001). With increasing creatinine values, the percentage of black patients increased progressively. The data draw attention to and elucidate the exceptionally high incidence of renal dysfunction in blacks with or without diabetes. Further, they may explain the inordinate numbers of blacks with hypertension requiring dialysis. Finally, these retrospective data suggest that prospective trials to test the effect of blood pressure and glucose control on the course of renal disease in hypertensive and/or type II diabetic patients are warranted.

AB - To test the hypothesis that race is a predictor of hypertensive renal disease, we examined a general medicine clinic population of 6,880 hypertensive patients who were treated for at least 1 year (mean, 5.2 years). Their mean age was 55.8 years; 70% were women, 72% were black, and 41% were diabetic (95% type II). Many were already under treatment at the time of enrollment. Their mean blood pressure at entry was 150/92 mmHg; during treatment it was 142/86 mmHg. Decreased renal function, defined as a serum creatinine ≥ 2 mg/dL, developed in 18.1%. A multivariable logistic regression analysis identified diabetes, glucose control, systolic blood pressure levels, heart failure, and male gender as indicators of decreased renal function. These data suggested that glucose and blood pressure control may decrease the frequency of impaired renal function. However, when these variables were controlled, blacks still had almost twice the risk for renal dysfunction (91% greater risk) than whites (P < 0.0001). With increasing creatinine values, the percentage of black patients increased progressively. The data draw attention to and elucidate the exceptionally high incidence of renal dysfunction in blacks with or without diabetes. Further, they may explain the inordinate numbers of blacks with hypertension requiring dialysis. Finally, these retrospective data suggest that prospective trials to test the effect of blood pressure and glucose control on the course of renal disease in hypertensive and/or type II diabetic patients are warranted.

UR - http://www.scopus.com/inward/record.url?scp=0024314633&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024314633&partnerID=8YFLogxK

M3 - Article

VL - 13

SP - 485

EP - 493

JO - American Journal of Kidney Diseases

JF - American Journal of Kidney Diseases

SN - 0272-6386

IS - 6

ER -